Professor, Laboratory Medicine, UCSF School of Medicine
Hematology
Dr. Andrew D. Leavitt, MD
|
|
Give Review
Andrew D. Leavitt, MD practices Hematology. He went to Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care He has 1 awards "Super Doctor". Doctor Andrew D. Leavitt, MD has written publications. He has 18 publications published with PubMed. The lastest publication is: 'Shedding a little light on posttransfusion purpura.' Andrew D. Leavitt, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Shedding a little light on posttransfusion purpura.
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
- Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis.
- Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report.
- Homologous recombination in human embryonic stem cells: a tool for advancing cell therapy and understanding and treating human disease.
- A vote for scientists as politicians.
- Are there more tricks in the bag for treating thrombocytopenia?
- Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures.
- Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs.
- A method for single-cell sorting and expansion of genetically modified human embryonic stem cells.
- A critical function for B-Raf at multiple stages of myelopoiesis.
- Caspase-12: a developmental link between G-protein-coupled receptors and integrin alphaIIbbeta3 activation.
- Raf-1 is not required for megakaryocytopoiesis or TPO-induced ERK phosphorylation.
- Using retroviruses to express genes in primary megakaryocyte lineage cells.
- Manipulation of mouse hematopoietic progenitors by specific retroviral infection.
- Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling.
- Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-s...
Schools
Harvard Medical School
University Of Michigan Health System
Doctors Specialties
- Internal Medicine
- Hematology
Accepted Insurances
Awards
- Super Doctor
Education
-
UCSF -
University of Michigan Hospitals and Health Centers -
Harvard Medical School
Hospital
-
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Randolph H. Chase, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John B. Davoren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald F. Murphy Sr., MD |
|
|
Dr. Basil P. Stamos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Caroline M. Behler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine C. Smith, MD |
|
|
Dr. Catherine A. Sanders, MD |